Publication | Closed Access

Mechanisms of genesis of variant translocation in chronic myeloid leukemia are not correlated with ABL1 or BCR deletion status or response to imatinib therapy

Hematological MalignancyChromatinChronic Myeloid LeukemiaBcr Deletion StatusVariant TranslocationHematologyMyeloid NeoplasiaAdult T-cell Leukemia-lymphomaRadiation OncologyMedicineCell BiologyTumor BiologyHealth Sciences